BioSante Pharmaceuticals’ LibiGel clinical revise to be presented in 2010 ISSWSH annual meeting BioSante Pharmaceuticals, Inc. Petersburg, Florida. BioSante is in Stage III advancement of LibiGel for the treating hypoactive libido disorder in menopausal ladies under an FDA approved SPA . BioSante is enrolling women in three Stage III clinical research with a fresh drug application prepared for mid-2011. We believe LibiGel could be first product to advertise for this unmet medical want. Snabes.Our show begins this Thursday evening at 6pm Pacific / 9pm Eastern, and registration is FREE. Just enter your email address in the registration type on the right column of this page and you’ll receive call-in information for the display. Targeting Cancer In America, half of all guys and one-third of most women will develop cancer throughout their lifetimes. Today, millions of people you live with cancers or have been cured of the disease. An individual patient’s chances of a cure increase the sooner a malignancy is found and the earlier treatment begins. Discover what that you can do on another NaturalNews Chat Hour. This week’s guest: James Forsythe, M.D., H.M.D. – Compassionate Oncology James Forsythe, M.D., H.M.D. – ‘Compassionate Oncology’ – Thu.